Takeda makes $61 billion bid for drugmaker Shire: sources
April 19, 2018 at 07:49 AM EDT
LONDON (Reuters) - Takeda Pharmaceutical has made a bid for Shire that values the London-listed drugmaker at around $61 billion, two sources with direct knowledge of the matter told Reuters.
